News and Reports
-
Ophthotech's novel Anti-PDGF combination agent Fovista TM demonstrated superior efficacy over Lucentis monotherapy in large controlled wet AMD trial
13 June 2012Download -
Top-Line data Phase 3 trial of Ataluren in Patients with Nonsense Mutation Cystic Fibrosis show promising results
8 June 2012Download -
Forest Laboratories and Nabriva Therapeutics sign agreement
1 June 2012Download -
Enanta signs collaboration with Novartis for Hepatitis C programme
22 February 2012Download -
Successful IPO of ChemoCentryx
9 February 2012Download -
ChemoCentryx licenses rheumatoid arthritis drug to GSK
6 January 2012Download -
PTC Therapeutics licenses SMA programme to Roche
30 November 2011Download -
Ellipse receives award for best new technology in spine care
15 November 2011Download -
Probiodrug announces top-line results of the first clinical study of PQ912 for treatment of Alzheimer's disease
14 November 2011Download -
ChemoCentryx reports clinical efficacy for CCX354 in Phase II study in Rheumatoid Arthritis
8 November 2011Download -
Pacira announces FDA approval of Exparel for pain
31 October 2011Download -
Pacira Pharmaceuticals announces U.S. FDA approval of EXPAREL(TM) for postsurgical pain management
31 October 2011Download -
ChemoCentryx initiates Phase II clinical trial for CCX168, a novel small molecule C5aR antagonist for the treatment of Vasculitis
17 October 2011Download -
Enanta awarded up to $42.7 million niaid contract to develop a novel broad spectrum bicyclolide antibiotic
13 October 2011Download -
Nabriva Therapeutics presents extended Phase II results for Pleuromutilin Antibiotic BC-3781
15 September 2011Download -
mtm laboratories to be acquired by Roche
19 July 2011Download -
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing
19 July 2011Download -
Delenex extends its A round to CHF 30.2 million
3 May 2011Download -
Anthera Pharmaceuticals successfully completes Interim Biomarker analysis of VISTA-16 study and third review of Varespladib Methyl
18 April 2011Download -
Mpex Pharmaceuticals, Inc. to be acquired by Axcan
14 April 2011Download -
HBM BioVentures: Successful sale of indirect holing in China Health System generates cash inflow of approximately USD 17 million
1 April 2011Download -
PTC Therapeutics appoints Robert Spiegel, M.D. as Chief Medical Officer
30 March 2011Download -
Pacira Pharmaceuticals, Inc. announces pricing of its Initial Public Offering
3 February 2011Download -
Valeant Pharmaceuticals to acquire PharmaSwis S.A.
1 February 2011Download -
Successful sale of HBM portfolio company PharmaSwiss to Valeant
1 February 2011Download